Clinical Trial Update: Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a denosumab biosimilar injected in postmenopausal women with osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab biosimilar injection (denosumab biosimilar)

Snippet

Sponsor: Lambda Therapeutic Research Ltd. | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: UNKNOWN